I guess some of the recent price weakness is due to this nonsense about Trump changing the US healthcare industry. However, the price seemed to have gotten way ahead of itself prior to that. Obviously they are doing very well and the CEO is extremely bullish. If they keep winning large contracts for the next few years then the high share price doesn't matter but you'd need to have a pretty clear view of the competitive landscape to be confident they can establish and maintain market leadership over that time.
Ann: Daily share buy-back notice - Appendix 3E, page-6
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$227.64 |
Change
5.890(2.66%) |
Mkt cap ! $17.90B | |||
| Open | High | Low | Value | Volume |
| $225.00 | $229.57 | $223.37 | $80.03M | 351.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4 | $227.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $227.72 | 3210 | 3 |
View Market Depth
| Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
| PME (ASX) Chart |
